Events
| Wed | ||
|---|---|---|
The Online Seminar shows the Possibilities of the use of Desktop-Sharing Software. The Online-Seminar is free of charge an will contain the following topic. How to Setup the Software. The Webinar will held on request, the duration is approx. 30 Minutes Further Information to the Online-Seminar Learn more: www.practicepaysolutions.com/mastery Join us for a free series of one-hour webinars with the a team of industry experts! We're presenting the less-covered, critical issues for small business owners, so you can reduce the time you spend on set-up and administration-- and focus on what really matters. Can't attend live? We'll send you the call recordings so you can access valuable information and share the event with your community! April 2nd: The Joy of Productivity with George Kao April 16th: How to Create Profitable Referral Partnerships with Robert Notter April 24th: Say Bye-Bye to Your Boring Bio with Nancy Juetten May 15th: From Contacts to Contracts with Caterina Rando May 22nd: Red Fire Profitability with Liz Goodgold June 5th: Developing Contracts & Service Agreements with Tasha Cooper Coleman June 19th: Outsourcing Secrets with Travis Greenlee July 10th: Your Money Relationship = Your Business Success with Helen Kim July 24th: How to Play a Bigger Marketing Game with Fabienne Fredrickson Allan Gonsher and Kids Inc are pleased to a offer a series of Play Therapy Webinars. If your work with children, or want to work with children, these are workshops that you can not afford to miss. Each webinar workshop offers one hour of continuing education credit. Start: 06/20/2012 10:00 am
Overview: This webinar will examine the stated intent of the Agency to get tougher across the board in its expectations for the medical industry and its compliance to the cGMPs. It will examine how these goals of the Agency have translated into action over the past two plus years: The changing focus of QSIT re: medical devices, and ICH Q8, Q9, and Q10 re: pharmaceuticals; Multi-site company operations, and the supply chain; Trends evident in 483 observations, Warning Letters, and recent major industry failures; Emphasis on proving a company is "in control" to an investigator's satisfaction; the negative role of "entropy", and proactive and reactive Warning Letter avoidance techniques. Why you should attend: The last few years have seen several major "names" in drugs and devices stumble over cGMP issues, resulting in recalls, lawsuits, and even possible criminal prosecution. As a result, there has been a major shift in the emphasis of the U.S. FDA cGMP compliance audit, also affecting clinical trial expectations, product submissions and company response requirements. This change in focus has a major impact on interpretation of individual compliance objectives, cGMP objectives, and measurements of success. Recent negative publicity on pharmaceuticals, devices, as well as events in unrelated industries has put pressure on the Agency to "get tough on compliance / enforcement". The public wants change. The U.S. FDA is responding. The cGMP compliance audit, validations, 510(k) submissions / data, "better science", lifecycles, closed-loop CAPA, outsourcing / globalization and supply chain / control issues, and senior management, are all under more intense scrutiny. Areas Covered In the Session: Who will benefit: Price List: webinars@globalcompliancepanel.com Phone: 800-447-9407 Start: 06/20/2012 10:00 am
End: 06/20/2012 11:00 am
This webinar will cover the basics of process validation for pharmaceutical products and give you a strong understanding of what is involved. It will provide beginners an understanding of the validation master plan, validation protocols, IQ, OQ, PQ and types of validation. Why Should You Attend: With new manufacturing technologies increasingly becoming a larger part of our pharmaceutical product supply, validation is gaining in importance to pharmaceutical manufacturers. Whether a firm performs its own validation, hires a validation contractor or delegates the responsibility to a third party contract manufacturer, the ultimate responsibility always falls to the firm whose name appears on the label. The only way that this can be done with confidence is to have an adequate number of validation experts on staff. Since many firms believe that they no longer need an in-house validation staff, they have done away with this overhead cost. Now it is essential to have a minimal on-site validation presence. Since there are very few validation experts today. It is often necessary to train people in this lost art. This webinar will cover the basics of validation. This 60-minute session will expose beginners to the basics of the process and give them a strong understanding of what is involved. Areas Covered in the Seminar: - What is validation and why is it important Start: 06/20/2012 10:00 am
Overview: The FDA’s Quality System Regulation (QSR) explains how a device manufacturer must manage suppliers. This ranges from supplier evaluation and selection to control methods. One common approach uses a supplier quality agreement. This webinar explains the elements of a supplier quality agreement and its implementation. Why should you attend: Effective supplier management can help prevent problems and reduce their impact should they occur. With the increased emphasis on supplier management, you can expect strong coverage of this area during an FDA Inspection. You need to understand the QSR requirements, good business practices, and the role of a quality agreement. This webinar will help you set up an effective system. Areas Covered in the Session: Who will benefit: Price List: webinars@globalcompliancepanel.com Phone: 800-447-9407 Start: 06/20/2012 11:00 am
Discover why Inattentive ADHD is different from other types of ADHD and learn the latest information about screening, SCT, symptomatology, comorbidities, treatment modalities, medication, and how this disorder may be mentioned in DSM-5. Full Description: This one-hour course will provide participants with the latest information about screening, Sluggish Cognitive Tempo (SCT), symptomatology, comorbidities, treatment modalities, medication, and how Inattentive ADHD may be mentioned in DSM-5. Course Includes: What You Will Learn: Your Presenter: Dr. Blake serves as a member of the American Psychological Association, International Dyslexia Association, Children and Adults with Attention Deficit Disorders, Learning Disabilities Association, and the National Attention Deficit Disorder Association and was a 1991 delegate to the National Institute for Literacy’s “LEAD 2000 Congress,” where he advised Congress on diagnostic and remediation issues. Disclaimer: Technical requirements: Who Should Attend: Start: 06/20/2012 1:00 pm
End: 06/20/2012 2:00 pm
Why should you Attend: • Create and use a recall operational procedure and what should it contain Webinar Includes: Q/A Session with the Expert to ask your question PDF print only copy of PowerPoint slides 60 Minutes Live Presentation Description of the topic: Recall means the correction or removal of a device for human use where FDA finds that there is a reasonable probability that the device would cause serious, adverse health consequences or death. It is an action taken to address a problem with a medical device that violates FDA law. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health. A medical device recall does not always mean that you must stop using the product or return it to the company. A recall sometimes means that the medical device needs to be checked, adjusted, or fixed. If an implanted device (for example, a pacemaker or an artificial hip) is recalled, it does not always have to be removed. When an implanted device has the potential to fail unexpectedly, companies often tell doctors to contact their patients to discuss the risk of removing the device compared to the risk of leaving it in place. FDA classifies medical device recalls into three categories, representing the potential risk to public health: Class I, II, and III. Who will benefit: (Titles) Manager, Regulatory About Speaker David R. Dills, Principal Consultant, PES-RAQA, Medical Device Practice, Wipro Technologies, currently provides regulatory and compliance consultative services to global medical device and pharmaceutical manufacturers, and also has an accomplished record with more than 23 years of experience with Class I/II/III medical devices, In Vitro diagnostics, and pharmaceuticals in the areas of QA, Regulatory Affairs and Compliance. Start: 06/20/2012 2:00 pm
End: 06/20/2012 3:00 pm
Negative keywords are one the most powerful tools available for marketers looking to optimize paid search and increase revenues. Join us for this FREE webcast to learn practical tips that the pros use for identifying, deploying, and profiting from negative keywords. You will discover: - How to identify negative keywords using data available in your enterprise today Start: 06/20/2012 4:00 pm
End: 06/20/2012 5:15 pm
This webinar will provide a detailed information on the critical requirements of ISO 17025 and recommendations for cost effective implementation. You will learn steps towards laboratory accreditation and how to prepare for an ISO 17025 audit. Why Should You Attend: ISO 17025 is used by laboratories as a standard to develop and establish a Quality System and for the assessment by their clients or by third parties. The standard is also being used as a criterion for laboratory accreditation. ISO 17025 is applicable to all organizations performing tests and/or calibrations, regardless of the number of personnel or the extent of the scope of testing and/or calibration. This webinar gives a detailed information on the critical requirements of ISO 17025 and recommendations for cost effective implementation. Hand-Outs:
Note: These complimentary hand-outs will be sent to customers on request. Please email customercare@complianceonline.com for these documents, stating your order number, and they will be emailed to you within 4 working days. Areas Covered in the Seminar: | ||
